MANGOCEUTICALS, INC. Reports Unregistered Equity Sale
Ticker: MGRX · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-securities, equity-sale, 8-k
TL;DR
MANGOCEUTICALS sold unregistered equity. Details in 8-K.
AI Summary
On March 25, 2025, MANGOCEUTICALS, INC. reported an unregistered sale of equity securities. The company, incorporated in Texas with its principal executive offices in Dallas, filed a Form 8-K to disclose this event. The filing details relate to the company's operations in the health and allied services sector.
Why It Matters
This filing indicates a transaction involving the company's equity that was not registered with the SEC, which could have implications for investors and regulatory compliance.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can sometimes indicate financial distress or a need for capital, and may carry specific risks for purchasers.
Key Players & Entities
- MANGOCEUTICALS, INC. (company) — Registrant
- March 25, 2025 (date) — Date of Earliest Event Reported
- Texas (location) — State of Incorporation
- Dallas (location) — City of Principal Executive Offices
- 873841292 (identifier) — IRS Employer Identification No.
- 001-41615 (identifier) — Commission File Number
FAQ
What type of equity securities were sold?
The filing does not specify the type of equity securities sold, only that it was an unregistered sale.
Were there any specific dollar amounts associated with this unregistered sale?
The provided text does not contain specific dollar amounts related to the unregistered sale of equity securities.
Who purchased the unregistered equity securities?
The filing does not disclose the identity of the purchasers of the unregistered equity securities.
What is the reason for the unregistered sale of equity securities?
The filing does not provide the specific reason or purpose behind the unregistered sale of equity securities.
Are there any ongoing legal or regulatory implications mentioned regarding this unregistered sale?
The filing does not detail any specific ongoing legal or regulatory implications arising from this unregistered sale.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding MANGOCEUTICALS, INC. (MGRX).